ArchiMed

News, insights, analysis and data

← Back to ArchiMed profile

ArchiMed related stories

All articles and analysis

  • Side Letter: The case for continuation
    Private Equity News & AnalysisPEI Staff- 25 October 2023

    There is an emerging body of evidence to suggest that continuation funds can deliver healthy returns. Plus: Japan's NSSK defies fundraising headwinds; and Pantheon has opened a brace of private wealth outposts. Here's today's brief, for our valued subscribers only.

  • ARCHIMED beats target with €3.5bn healthcare fund
    Private Equity News & AnalysisCarmela Mendoza- 5 June 2023

    The healthcare-focused firm has more than doubled its firepower for its latest buy-and-build-focused vehicle.

  • Side Letter: KKR's $8bn close; 5x continuation vindication; CalSTRS' two-pronged climate plan
    Private Equity News & AnalysisPEI Staff- 4 April 2023

    KKR has closed its latest European flagship. Plus: How CalSTRS aims to deploy billions into climate investing; and the SEC is taking a closer look at third-party valuations. Here’s today's brief, for our valued subscribers only.

  • ArchiMed scores 300x return for debut fund with Polyplus exit
    Private Equity Deals & TransactionsMadeleine Farman- 4 April 2023

    ArchiMed and Warburg Pincus have agreed to sell the France-headquartered business to life science group Sartorius for approximately €‎2.4bn.

  • Side Letter: TPG's $39bn arsenal; LPs' unplanned calls; PE's ESG talent edge
    Private Equity News & AnalysisPEI Staff- 10 August 2022

    TPG might unleash its $39 billion mountain of dry powder on public companies. Plus: IR professionals are fielding hours of unexpected LP calls in this heady fundraising environment; and why private equity has an edge in the ESG talent tussle. Here's today's brief, for our valued subscribers only.

  • ArchiMed raises €650m
    Omar Alam- 9 August 2021

    MED III holds a final close.

  • Europe most attractive for cross-border deals – report
    Private Equity News & AnalysisCarmela Mendoza- 8 July 2021

    More than one-third of GPs expect full normalisation of cross-border dealmaking before the end of this year, according to a report from corporate services provider Auxadi.

  • A-Z of Healthcare: F-K
    Private Equity News & AnalysisPEI Staff- 1 July 2021

    The second part of our A-Z looks at financing, growth, healthtech, infectious diseases, joint ownership and KOLs.

  • A-Z of Healthcare: L-P
    PEI Staff- 1 July 2021

    The third part of our A-Z looks at logistics, mental health, nursing homes, outcomes and pharmaceuticals.

  • A-Z of Healthcare: A-E
    Private Equity News & AnalysisPEI Staff- 1 July 2021

    In the first part of our A-Z, we examine ancillary healthcare, biotech, covid-19, digitisation and eldercare.